Reaching the Masses: Novartis' Commitment to Broad Access
Novartis is committed to ensuring that their medicines are accessible to patients worldwide, regardless of their background or location. In Bangladesh, Novartis has embarked on a transformative journey to reshape their business practices and reimagine ways to expand access to crucial healthcare innovations.
To achieve this goal, Novartis has implemented various strategies. They have adopted innovative pricing and access models, allowing for broader availability of their medicines. They have also redirected their research and development efforts to focus on addressing society’s healthcare needs, ensuring that their innovations are aligned with the most pressing healthcare challenges.
In addition, Novartis is actively supporting approaches that strengthen healthcare systems in Bangladesh. By collaborating with partners across sectors and industries, Novartis aims to maximize its impact on patient health outcomes.
A recent example of their commitment to accessibility is demonstrated through the Novartis global Managed Access Program. In collaboration with the National Institute of Neurosciences & Hospital, Novartis provided a gene therapy treatment worth approximately BDT 22 crore to a child, completely free of cost. This initiative highlights Novartis’ dedication to ensuring that life-saving treatments are available to those in need.
Novartis continues to work tirelessly to break down barriers to healthcare access, demonstrating their commitment to improving patient outcomes and making a positive impact on society.